Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
QQ7rVTn3SXxwj0QV
Listen
